TY - JOUR
T1 - Rationale and design of the ABOARD project (A Personalized Medicine Approach for Alzheimer's Disease)
AU - Dreves, Maria A.E.
AU - van Harten, Argonde C.
AU - Visser, Leonie N.C.
AU - Rhodius-Meester, Hanneke
AU - Köhler, Sebastian
AU - Kooistra, Minke
AU - Papma, Janne M.
AU - Honey, Madison I.J.
AU - Blom, Marco M.
AU - Smets, Ellen M.A.
AU - de Vugt, Marjolein E.
AU - Teunissen, Charlotte E.
AU - van der Flier, Wiesje M.
N1 - Publisher Copyright:
© 2023 The Authors. Alzheimer's & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
PY - 2023/4/1
Y1 - 2023/4/1
N2 - The key to stopping Alzheimer's disease (AD) lies in the pre-dementia stages, with the goal to stop AD before dementia has started. We present the rationale and design of the ABOARD (A Personalized Medicine Approach for Alzheimer's Disease) project, which aims to invest in personalized medicine for AD. ABOARD is a Dutch public–private partnership of 32 partners, connecting stakeholders from a scientific, clinical, and societal perspective. The 5-year project is structured into five work packages on (1) diagnosis, (2) prediction, (3) prevention, (4) patient-orchestrated care, and (5) communication and dissemination. ABOARD functions as a network organization in which professionals interact cross-sectorally. ABOARD has a strong junior training program “Juniors On Board.” Project results are shared with society through multiple communication resources. By including relevant partners and involving citizens at risk, patients, and their care partners, ABOARD builds toward a future with personalized medicine for AD. Highlights: ABOARD (A Personalized Medicine Approach for Alzheimer's Disease) is a public–private research project executed by 32 partners that functions as a network organization. Together, the project partners build toward a future with personalized medicine for Alzheimer's disease. Although ABOARD is a Dutch consortium, it has international relevance. ABOARD improves diagnosis, prediction, prevention, and patient-orchestrated care.
AB - The key to stopping Alzheimer's disease (AD) lies in the pre-dementia stages, with the goal to stop AD before dementia has started. We present the rationale and design of the ABOARD (A Personalized Medicine Approach for Alzheimer's Disease) project, which aims to invest in personalized medicine for AD. ABOARD is a Dutch public–private partnership of 32 partners, connecting stakeholders from a scientific, clinical, and societal perspective. The 5-year project is structured into five work packages on (1) diagnosis, (2) prediction, (3) prevention, (4) patient-orchestrated care, and (5) communication and dissemination. ABOARD functions as a network organization in which professionals interact cross-sectorally. ABOARD has a strong junior training program “Juniors On Board.” Project results are shared with society through multiple communication resources. By including relevant partners and involving citizens at risk, patients, and their care partners, ABOARD builds toward a future with personalized medicine for AD. Highlights: ABOARD (A Personalized Medicine Approach for Alzheimer's Disease) is a public–private research project executed by 32 partners that functions as a network organization. Together, the project partners build toward a future with personalized medicine for Alzheimer's disease. Although ABOARD is a Dutch consortium, it has international relevance. ABOARD improves diagnosis, prediction, prevention, and patient-orchestrated care.
KW - Alzheimer's disease
KW - diagnosis
KW - patient-orchestrated care
KW - personalized medicine
KW - prediction
KW - prevention
UR - http://www.scopus.com/inward/record.url?scp=85168288519&partnerID=8YFLogxK
U2 - 10.1002/trc2.12401
DO - 10.1002/trc2.12401
M3 - Article
AN - SCOPUS:85168288519
SN - 2352-8737
VL - 9
JO - Alzheimer's and Dementia: Translational Research and Clinical Interventions
JF - Alzheimer's and Dementia: Translational Research and Clinical Interventions
IS - 2
M1 - e12401
ER -